{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:02:55Z","timestamp":1792699375322,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD015946"],"award-info":[{"award-number":["U54MD015946"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD015946"],"award-info":[{"award-number":["U54MD015946"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s00520-024-08619-8","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T10:29:28Z","timestamp":1717496968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunomodulator adherence in multiple myeloma patients with lower socioeconomic status: a retrospective study"],"prefix":"10.1007","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5662-4686","authenticated-orcid":false,"given":"Onyebuchi","family":"Ononogbu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oyinkansola","family":"Akindele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Yazdanfard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilqees","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Abughosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghana V.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"issue":"3","key":"8619_CR1","doi-asserted-by":"publisher","first-page":"155","DOI":"10.5001\/omj.2011.38","volume":"26","author":"B Jimmy","year":"2011","unstructured":"Jimmy B, Jose J (2011) Patient medication adherence: measures in daily practice. Oman Med J 26(3):155\u2013159. https:\/\/doi.org\/10.5001\/omj.2011.38","journal-title":"Oman Med J"},{"issue":"8","key":"8619_CR2","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.3390\/ijerph18084266","volume":"18","author":"A Talens","year":"2021","unstructured":"Talens A, Guilabert M, Lumbreras B, Aznar MT, L\u00f3pez-Pintor E (2021) Medication experience and adherence to oral chemotherapy: a qualitative study of patients\u2019 and health professionals\u2019 perspectives. Int J Environ Res Public Health 18(8):4266. https:\/\/doi.org\/10.3390\/ijerph18084266","journal-title":"Int J Environ Res Public Health"},{"issue":"9","key":"8619_CR3","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/jnci\/94.9.652","volume":"94","author":"AH Partridge","year":"2002","unstructured":"Partridge AH, Avorn J, Wang PS, Winer EP (2002) Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94(9):652\u2013661. https:\/\/doi.org\/10.1093\/jnci\/94.9.652","journal-title":"J Natl Cancer Inst"},{"key":"8619_CR4","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1186\/s12885-017-3735-1","volume":"17","author":"L Bouwman","year":"2017","unstructured":"Bouwman L, Eeltink CM, Visser O, Janssen JJWM, Maaskant JM (2017) Prevalence and associated factors of medication non-adherence in hematological-oncological patients in their home situation. BMC Cancer 17:739. https:\/\/doi.org\/10.1186\/s12885-017-3735-1","journal-title":"BMC Cancer"},{"key":"8619_CR5","unstructured":"SEER cancer stat facts: myeloma. National Cancer Institute. Bethesda, MD Web site. https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html Accessed Jul 14, 2023"},{"key":"8619_CR6","unstructured":"Hematologic cancer incidence, survival, and prevalence | CDC. https:\/\/www.cdc.gov\/cancer\/uscs\/about\/data-briefs\/no30-hematologic-incidence-surv-prev.htm Updated 2022. Accessed Jul 14, 2023"},{"issue":"8","key":"8619_CR7","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1002\/ajh.26590","volume":"97","author":"SV Rajkumar","year":"2022","unstructured":"Rajkumar SV (2022) Multiple myeloma: 2022 update on diagnosis, risk-stratification and management. Am J Hematol 97(8):1086\u20131107. https:\/\/doi.org\/10.1002\/ajh.26590","journal-title":"Am J Hematol"},{"issue":"9","key":"8619_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.6004\/jnccn.2009.0061","volume":"7","author":"KC Anderson","year":"2009","unstructured":"Anderson KC, Alsina M, Bensinger W et al (2009) NCCN clinical practice guidelines in oncology: multiple myeloma. J Natl Compr Canc Netw 7(9):908\u2013942. https:\/\/doi.org\/10.6004\/jnccn.2009.0061","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"8619_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clml.2019.09.618","volume":"20","author":"H Mian","year":"2020","unstructured":"Mian H, Fiala M, Wildes TM (2020) Adherence to lenalidomide in older adults with newly diagnosed multiple myeloma. Clin Lymphoma Myeloma Leuk 20(2):98-104.e1. https:\/\/doi.org\/10.1016\/j.clml.2019.09.618","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"4","key":"8619_CR10","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/pon.5011","volume":"28","author":"I Ruiz-P\u00e9rez","year":"2019","unstructured":"Ruiz-P\u00e9rez I, Rodr\u00edguez-G\u00f3mez M, Pastor-Moreno G, Escrib\u00e1-Ag\u00fcir V, Petrova D (2019) Effectiveness of interventions to improve cancer treatment and follow-up care in socially disadvantaged groups. Psychooncology 28(4):665\u2013674. https:\/\/doi.org\/10.1002\/pon.5011","journal-title":"Psychooncology"},{"key":"8619_CR11","unstructured":"Harris Health System: Facts and Figures. harrishealth.org Web site. https:\/\/www.harrishealth.org\/about-us-hh\/who-we-are\/Pages\/statistics.aspx. Accessed 14 Aug 2023"},{"issue":"12","key":"8619_CR12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.6004\/jnccn.2020.0057","volume":"18","author":"SK Kumar","year":"2020","unstructured":"Kumar SK, Callander NS, Adekola K et al (2020) Multiple Myeloma, Version 3.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 18(12):1685\u20131717. https:\/\/doi.org\/10.6004\/jnccn.2020.0057","journal-title":"J Natl Compr Canc Netw"},{"key":"8619_CR13","unstructured":"StataCorp. 2. Stata Statistical Software: Release 18. StataCorp LLC, College Station"},{"issue":"6","key":"8619_CR14","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/s11096-023-01609-6","volume":"45","author":"S Rahimi","year":"2023","unstructured":"Rahimi S, Ononogbu O, Mohan A, Moussa D, Abughosh S, Trivedi MV (2023) Adherence to oral endocrine therapy in racial\/ethnic minority patients with low socioeconomic status before and during the COVID-19 pandemic. Int J Clin Pharm 45(6):1396\u20131404. https:\/\/doi.org\/10.1007\/s11096-023-01609-6","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"8619_CR15","doi-asserted-by":"publisher","first-page":"e0214446","DOI":"10.1371\/journal.pone.0214446","volume":"14","author":"A Cransac","year":"2019","unstructured":"Cransac A, Aho S, Chretien M, Giroud M, Caillot D, Boulin M (2019) Adherence to immunomodulatory drugs in patients with multiple myeloma. PLoS ONE 14(3):e0214446. https:\/\/doi.org\/10.1371\/journal.pone.0214446","journal-title":"PLoS ONE"},{"issue":"7","key":"8619_CR16","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1007\/s00277-021-04543-7","volume":"100","author":"M Solano","year":"2021","unstructured":"Solano M, Daguindau E, Faure C et al (2021) Oral therapy adherence and satisfaction in patients with multiple myeloma. Ann Hematol 100(7):1803\u20131813. https:\/\/doi.org\/10.1007\/s00277-021-04543-7","journal-title":"Ann Hematol"},{"issue":"10","key":"8619_CR17","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.clml.2022.05.003","volume":"22","author":"AY Naser","year":"2022","unstructured":"Naser AY, Ofori-Asenso R, Awawdeh SA, Qadus S, Alwafi H, Liew D (2022) Real world adherence to and persistence with oral oncolytics in multiple myeloma: a systematic review and meta-analysis. Clin Lymphoma Myeloma Leuk 22(10):760\u2013773. https:\/\/doi.org\/10.1016\/j.clml.2022.05.003","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"8","key":"8619_CR18","doi-asserted-by":"publisher","first-page":"e2225485","DOI":"10.1001\/jamanetworkopen.2022.25485","volume":"5","author":"X Hu","year":"2022","unstructured":"Hu X, Walker MS, Stepanski E et al (2022) Racial differences in patient-reported symptoms and adherence to adjuvant endocrine therapy among women with early-stage, hormone receptor-positive breast cancer. JAMA Netw Open 5(8):e2225485. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.25485","journal-title":"JAMA Netw Open"},{"key":"8619_CR19","doi-asserted-by":"publisher","unstructured":"Ding A, Dixon SW, Ferries EA, Shrank WH (2022) The role of integrated medical and prescription drug plans in addressing racial and ethnic disparities in medication adherence. J Manag Care Spec Pharm 28(3):https:\/\/doi.org\/10.18553\/jmcp.2022.28.3.379","DOI":"10.18553\/jmcp.2022.28.3.379"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08619-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-08619-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-08619-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T09:10:14Z","timestamp":1721034614000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-08619-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["8619"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-08619-8","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"1 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"407"}}